VELMANASE ALFA 10 MG PÓ SOL INJ FR IV
TED · 741241-2026Award noticeawardedNo deadline given
Value
Estimated—
Awarded€369,287 · 369,286.72 EUR
WinnerCencora 3Pl Portugal, S.A.
Who already wins at this buyer
Firms with recorded awards from Unidade Local de Saúde de Coimbra, EPE in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| Brainlab Sales GmbH | 2 | €2,619,329 | 2026-10-08 |
| Roche Farmacêutica Química, Lda. | 2 | — | 2026-10-08 |
| Takeda Farmacêuticos Portugal, Lda | 1 | €1,828,250 | 2026-07-17 |
| Cencora 3PL Portugal, S.A. | 1 | €1,435,097 | 2026-07-20 |
| Getinge Group Portuga, Unipessoal, Lda. | Iberdata Equipamentos, SA | 1 | €1,412,619 | 2026-05-21 |
Full buyer profile: what Unidade Local de Saúde de Coimbra, EPE buys and who wins it →
CPV codes
33600000 Medical equipment & pharmaceuticalsDescription
Aquisição de "VELMANASE ALFA 10 MG PÓ SOL INJ FR IV"
Similar tenders
Closest by meaning — across languages, via embeddings.
| Published | Title | Buyer | Match |
|---|---|---|---|
| 2026-10-27 | VELMANASE ALFA 10 MG PÓ SOL INJ FR IV | Unidade Local de Saúde de Coimbra, EPE PT | 100% |
| 2026-10-23 | BINIMETINIB 45 MG COMP | Unidade Local de Saúde de Coimbra, EPE PT | 94% |
| 2026-07-20 | Maralixibat 9.5 Mg/mL Sol Oral Fr 30 mL | Unidade Local de Saúde de Coimbra, EPE PT | 93% |
| 2026-09-14 | Com base no cpa 2025_1303 - Glofitamab - justificação clinica | Unidade Local de Saúde de Coimbra, EPE PT | 93% |
| 2026-07-17 | Rurioctocog Alfa Pegol Pó Sol Inj Fr Iv | Unidade Local de Saúde de Coimbra, EPE PT | 93% |
| 2026-10-27 | ZANUBRUTINIB 160 MG COMP | Unidade Local de Saúde de Coimbra, EPE PT | 93% |